# Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility

> **NCT04748796** · PHASE3 · RECRUITING · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 360 (estimated)

## Conditions studied

- Septic Shock
- Tachycardia
- Mortality During Septic Shock
- Beta-blocker

## Interventions

- **OTHER:** echocardiography
- **DRUG:** Landiolol

## Key facts

- **NCT ID:** NCT04748796
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-01
- **Primary completion:** 2027-06
- **Final completion:** 2027-09
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04748796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04748796, "Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04748796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*